FDA issues safety alert on breast implant-associated cancers
The Food and Drug Administration yesterday alerted health care providers and the public to reports of squamous cell carcinoma in scar tissue around breast implants, as well as lymphomas different than those previously associated with breast implants. The agency recommends that health care providers continue to report cancers around breast implants to help it identify and better understand this emerging issue.
Related News Articles
Headline
Caitlin Gillooley, AHA director of quality and behavioral health policy, and Evelyn Ivy Mwangi, M.D., Luminis Health Anne Arundel Medical Center geriatric…
Blog
Food insecurity doesn’t always mean going hungry — it can also mean not having access to nutritious food. At Cleveland Clinic, leaders see nutritious food as…
Perspective
As of 2024, there were about 61 million Americans age 65 and older, according to the U.S. Census Bureau, representing about 18% of the total U.S.…
Headline
Jon Zifferblatt, M.D., executive vice president and chief strategy officer at West Health, and Diane Wintz, M.D., critical care specialist and medical director…
Headline
Inova Health System’s Toni Ardabell, chief of clinical enterprise operations, and Sage Bolte, Ph.D., chief philanthropy officer and president of the Inova…
Perspective
All of America’s hospitals and health systems, regardless of ownership status, size or location, provide a vast range of benefits, programs and essential…